All
Ocriplasmin: Clinically meaningful increases in visual function in symptomatic vitreomacular adhesion
Treatment with a single ocriplasmin injection led to clinically meaningful improvements in the patient-reported visual function measured by the VFQ-25 questionnaire over 24 months in patients with symptomatic vitreomacular adhesion.
ILM peeling prevents development of ERMs
Only 2% of patients with internal limiting membrane peeling developed an epiretinal membrane compared with 46% with no peeling.
FAF sheds light on patterns related to disease chronicity in CSC
Fundus autofluorescence is a helpful tool for diagnosing central serous choroidopathy and planning treatment.
Anti-VEGF therapy may prevent/delay radiation maculopathy in choroidal melanoma
Immediate administration after radiation therapy is key.
Company seeks first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications
Patient enrollment for the NORSE 2 clinical trial has been completed, with safety and efficacy data expected to be reported in the third quarter of 2021.
Noninfectious uveitis: Meeting the challenge
Chronic cases can be difficult for retina specialists; treatment is satisfying.
Improving patient comfort with intravitreal injections
Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.
Face-down positioning better after detached retina repair
Face-down positioning is associated with a reduction in certain complications following macula-involving retinal displacement (RD) repair, according to researchers.
Subretinal gene therapy safe with visual benefit
This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.
Role of human amniotic membrane in surgery of recurrent macular holes
Determining risk of ocular damage from chronic intravitreal injections
PACK-CXL researchers continue to clear hurdles of topical drugs
Technology 'perfect' for pediatric neuro-ophthalmology diagnoses
Pharmacologic treatment an option for open-angle glaucoma
COVID-19: Putting safety measures into practice
COVID-19: Impact of pandemic on Switzerland's ophthalmic space
COVID-19: Keeping staff and patients safe during a pandemic
COVID-19: Life in the time of coronavirus
ASRS 2019 Street Team: Dr. Rishi Singh
ASRS 2019 Street Team: Josh Anderson
ASRS 2019 Street Team: Chuck Hess
Meta-analysis on DME treatments updated to include treatment regimen
FISH in focus for fast eye infection diagnosis
Despite cost, advantages include sensitivity, improved outcomes
US, international physicians mostly in agreement over treatment practices
This year’s ASRS PAT survey show subtle regional differences
Global trends show similar patterns worldwide
The ASRS Global Trends Survey finds differences in some treatment preferences
ASRS 2019 Street Team: John T. Thompson, MD
ICYMI: ASRS-developed program aims to support physicians with confidential comparisons
ASRS 2019 Street Team: Netan Choudhry, MD, FRCSC, DABO
Defining medicine and terms used can help move science forward
ASRS 2019 Street Team: Justis P. Ehlers, MD
Researchers seeking fluid features, retinal integrity measures to test next step in image analysis and image interrogation in clinical trials.
ASRS 2019 Street Team: David S. Boyer, MD
David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.
Intravenous prostaglandin E1 infusion for acute central retinal artery occlusion
The study finds that treatment resulted in a significant visual improvement.
